Literature DB >> 3694664

Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.

J A Armstrong1, S H Wee, C S Goodwin, D H Wilson.   

Abstract

Campylobacter pyloridis was cultured for maximal growth in liquid medium, and effects of exposure to various beta-lactam and macrolide antibiotics, metronidazole, tripotassium dicitrato bismuthane (TDB) and cimetidine were monitored by transmission electronmicroscopy after periods of exposure up to 24 h. With amoxycillin and benzylpenicillin (0.12-1 mg/L) and cephalexin (2 mg/L) the normal bacilliform morphology was replaced by bulging and dumb-bell-like profiles showing cell-wall blebbing and vesiculation, and eventually by swollen forms with incomplete cell walls undergoing lysis. These changes developed progressively between 2 h and 24 h and were accelerated at the higher antibiotic concentrations. Erythromycin and clindamycin caused central clearing, ribosomal coagulation and impaired cross-wall formation. There were no gross structural changes in the presence of metronidazole (4 mg/L), TDB (1000 and 2400 mg/L) or cimetidine (1000 and 2000 mg/L); but with TDB focal accumulation of particulate bismuth complex was detected under the cell wall, affecting nearly all organisms by 24 h. In parallel viability tests, metronidazole and TDB both showed bactericidal activity, but cimetidine did not. These findings support the clinical experience that favours combination therapy with bismuth plus an appropriate systemic antibiotic as the regimen of choice for effective clearance of the organisms in C. pyloridis-associated gastritis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3694664     DOI: 10.1099/00222615-24-4-343

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  27 in total

1.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Authors:  T Iwahi; H Satoh; M Nakao; T Iwasaki; T Yamazaki; K Kubo; T Tamura; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori.

Authors:  Morris O Makobongo; Hanan Gancz; Beth M Carpenter; Dennis P McDaniel; D Scott Merrell
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni.

Authors:  M L Hänninen
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

4.  Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori.

Authors:  M R Millar; J Pike
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Morphological effects of miconazole on Helicobacter pylori.

Authors:  G von Recklinghausen; E N Schmid; A Vollmer; R Ansorg
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

6.  Activity of cefixime against Helicobacter pylori and affinities for the penicillin-binding proteins.

Authors:  F Ikeda; Y Yokota; Y Mine; M Tatsuta
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

7.  Deposition of bismuth by Yersinia enterocolitica.

Authors:  O W Nadeau; D W Gump; G M Hendricks; D H Meyer
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

8.  The antibody titers to Helicobacter pylori in 7 - 12 year old iron deficiency anemic children, in Ilam.

Authors:  Morteza Hoseinzadeh; Afra Khosravi; Koroush Sayemiri; Mohammad Hossein Rasoli; Alireza Mohaveri
Journal:  J Res Med Sci       Date:  2010-11       Impact factor: 1.852

9.  Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.

Authors:  P E Coudron; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity.

Authors:  G S Sandha; R LeBlanc; S J Van Zanten; T D Sitland; L Agocs; N Burford; L Best; D Mahoney; P Hoffman; D J Leddin
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.